Catalyst Wire Dossier Catalyst Wire Dossier

ZYNYZ

RETIFANLIMAB-DLWR · Incyte Corporation
Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for ZYNYZ, covering 2021-11-29 to 2026-03-30. Get the full timeline:

Most recent: FDA Approved: ZYNYZ — Supplemental Application (Incyte Corporation)

See pricing